Cited by 305Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersTGF-β signaling in diseases

The DOI matches its Crossref record; 65 of the 69 references it cites were found in a registry or an index.

Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer

Open access

Chen, Yang, Yang, Sujuan, Tavormina, Jena, Tampe, Desiree, Zeisberg, Michael, Wang, Huamin, Mahadevan, Krishnan K., Wu, Chang-Jiun, Sugimoto, Hikaru, Chang, Chia-Chi, Jenq, Robert R., McAndrews, Kathleen M., Kalluri, Raghu·2022·Cancer Cell

DOI 10.1016/j.ccell.2022.06.011PMC PMC9831277

Open this paper in CoChat — free account

Abstract

In contrast to normal type I collagen (Col1) heterotrimer (α1/α2/α1) produced by fibroblasts, pancreatic cancer cells specifically produce unique Col1 homotrimer (α1/α1/α1). Col1 homotrimer results from epigenetic suppression of the Col1a2 gene and promotes oncogenic signaling, cancer cell proliferation, tumor organoid formation, and growth via α3β1 integrin on cancer cells, associated with tumor microbiome enriched in anaerobic Bacteroidales in hypoxic and immunosuppressive tumors. Deletion of Col1 homotrimers increases overall survival of mice with pancreatic ductal adenocarcinoma (PDAC), associated with reprograming of the tumor microbiome with increased microaerophilic Campylobacterales, which can be reversed with broad-spectrum antibiotics. Deletion of Col1 homotrimers enhances T cell infiltration and enables efficacy of anti-PD-1 immunotherapy. This study identifies the functional impact of Col1 homotrimers on tumor microbiome and tumor immunity, implicating Col1 homotrimer-α3β1 integrin signaling axis as a cancer-specific therapeutic target.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2022.06.011

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Self-citation
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488

Show all 69 references

Research works printed but not linked: 1

Lee, 2012, Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice, Dis. Models Mech., 5, 397

Sorted by citations

Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Falcomatà, C., Bärthel, S., Schneider, G., Rad, R., Schmidt‐Supprian, M., & Saur, D. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0876 · Cited by 224
Barriers and opportunities in pancreatic cancer immunotherapy
Ju, Y., Xu, D., Liao, M.-M., Sun, Y., Bao, W.-D., Yao, F., & Ma, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00681-z · Cited by 174
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 162
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Schenkel, J. M., & Pauken, K. E. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00884-8 · Cited by 144
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy
Hu, Q., Zhu, Y., Mei, J., Liu, Y. L., & Zhou, G. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01717-y · Cited by 157
The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer‐associated fibroblast subtypes
Thorlacius‐Ussing, J., Jensen, C., Nissen, N. I., Cox, T. R., Kalluri, R., Karsdal, M. A., & Willumsen, N. (2023) · The Journal of Pathology · doi:10.1002/path.6207 · Cited by 105
Self-citation
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Hanahan, D., Michielin, O. A., & Pittet, M. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00761-z · Cited by 106
Collagen architecture and signaling orchestrate cancer development
Su, H., & Karin, M. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.002 · Cited by 88
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Gautam, S. K., Batra, S. K., & Jain, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01813-y · Cited by 93
The molecular classification of cancer‐associated fibroblasts on a pan‐cancer single‐cell transcriptional atlas
Chen, B., Chan, W. N., Xie, F., Mui, C. W., Liu, X., Cheung, A. H. K., Lung, R. W. M., Chow, C., Zhang, Z., Fang, C., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1516 · Cited by 80
Mechanism of Action of Collagen and Epidermal Growth Factor: A Review on Theory and Research Methods
Shahrajabian, M. H., & Sun, W. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230816090054 · Cited by 80
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Flies, D. B., Langermann, S., Jensen, C., Karsdal, M. A., & Willumsen, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199513 · Cited by 79
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Luo, W., Wen, T., & Qu, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02935-3 · Cited by 73
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Hilmi, M., Delaye, M., Muzzolini, M., Nicolle, R., Cros, J. F., Hammel, P. R., Cardot‐Ruffino, V., & Neuzillet, C. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00207-8 · Cited by 75
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 86
Targets of tumor microenvironment for potential drug development
Zhang, L., Wang, Z., Liu, K., Liu, Y., Wang, S., Jiang, W., Lu, F., & Dang, Y. (2024) · MedComm – Oncology · doi:10.1002/mog2.68 · Cited by 68
Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer
Wang, N., Wu, S., Huang, L., Hu, Y., He, X., He, J., Hu, B., Xu, Y., Rong, Y., Yuan, C., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01117-x · Cited by 62
Metabolic control of collagen synthesis
Guillard, J., & Schwörer, S. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.07.003 · Cited by 65
Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation
Sun, W., Zhang, H., Xie, W., Ma, L., Dang, Y., Liu, Y., Li, L., Qu, F., & Tan, W. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c04794 · Cited by 60
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications
Faisal, S. M., Comba, A., Varela, M. L., Argento, A. E., Brumley, E. K., Abel, C. C., Castro, M. G., & Lowenstein, P. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005069 · Cited by 58
Multifaceted collagen-DDR1 signaling in cancer
Su, H., & Karin, M. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.08.003 · Cited by 55
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma
Yang, X., Zhang, Z., Shen, X., Xu, J., Weng, Y., Wang, W., & Xue, J. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00831-8 · Cited by 52
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy
Baldari, S., Modugno, F. D., Nisticò, P., & Toietta, G. (2022) · Cancers · doi:10.3390/cancers14194706 · Cited by 53
TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ Macrophages
Yang, D., Sun, X., Wang, H., Wistuba, I. I., Wang, H., Maitra, A., & Chen, Y. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.01.244 · Cited by 56
Self-citation
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Moeckel, C. M., Bakhl, K., Georgakopoulos‐Soares, I., & Zaravinos, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076710 · Cited by 52
Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy
Gong, P., Wang, F., Hua, Y., Ying, J., Chen, J., & Qiao, Y. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03815-y · Cited by 57
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Papakonstantinou, A., Nuciforo, P. G., Borrell, M., Zamora, E., Pimentel, I., Saura, C., & Oliveira, M. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102470 · Cited by 45
Flourishing tumor organoids: History, emerging technology, and application
Yang, Q., Li, M., Yang, X., Xiao, Z., Tong, X., Tuerdi, A., Li, S., & Lei, L. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10559 · Cited by 46
Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy
Borst, R., Meyaard, L., & Ramos, M. I. P. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05199-3 · Cited by 53
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Chakkera, M., Foote, J. B., Farran, B., & Nagaraju, G. P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189065 · Cited by 48
Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy
Yang, D., Sun, X., Moniruzzaman, R., Wang, H., Citu, C., Zhao, Z., Wistuba, I. I., Wang, H., Maitra, A., & Chen, Y. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.03.007 · Cited by 44
Self-citation
Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
Tabrizi, E., Tabrizi, F. P. F., Khaled, G. M., Sestito, M. P., Jamie, S., & Boone, B. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1434771 · Cited by 43
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 45
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma
Shen, X., Xie, S., Zheng, X. M., Zou, T., Hu, B., Xu, J., Liu, L., Xu, Y., Wang, X., Wang, H., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00476-9 · Cited by 40
Self-citation
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer
Ippolito, L., Duatti, A., Iozzo, M., Comito, G., Pardella, E., Lorito, N., Bacci, M., Pranzini, E., Santi, A., Sandrini, G., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00180-z · Cited by 41
Microbiome and pancreatic cancer: time to think about chemotherapy
de Castilhos, J., Tillmanns, K., Blessing, J., Larano, A., Borisov, V., & Stein‐Thoeringer, C. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2374596 · Cited by 41
RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy
Sanati, M., Afshari, A. R., Aminyavari, S., Kesharwani, P., Jamialahmadi, T., & Sahebkar, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104562 · Cited by 40
Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
Li, O., Li, L., Sheng, Y., Ke, K., Wu, J., Mou, Y., Liu, M., & Jin, W. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216391 · Cited by 38
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 42
The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
Mima, K., Hamada, T., Inamura, K., Baba, H., Ugai, T., & Ogino, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2269623 · Cited by 39
Inferring cell trajectories of spatial transcriptomics via optimal transport analysis
Shen, X., Zuo, L., Ye, Z., Yuan, Z., Huang, K., Li, Z., Yu, Q., Zou, X., Wei, X., Xu, P., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101194 · Cited by 36
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality
Guillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.004 · Cited by 36
Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer
Chen, F., Yang, J., Guo, Y., Su, D., Sheng, Y., & Wu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140995 · Cited by 38
Reactivation of embryonic genetic programs in tissue regeneration and disease
Fazilaty, H., & Basler, K. (2023) · Nature Genetics · doi:10.1038/s41588-023-01526-4 · Cited by 43
The Multifaced Role of Collagen in Cancer Development and Progression
Buglio, G. L., Cicero, A. L., Campora, S., & Ghersi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413523 · Cited by 38
Intratumour microbiome of pancreatic cancer
Guan, S.-W., Lin, Q., & Yu, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.713 · Cited by 34
Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance
Fu, Y., Guo, X., Sun, L., Cui, T., Wu, C., Wang, J., Liu, Y., & Liu, L. (2024) · eLife · doi:10.7554/elife.95009 · Cited by 31
Self-citation
Novel roles for cooperating collagen receptor families in fibrotic niches
Zeltz, C., Kusche‐Gullberg, M., Heljäsvaara, R., & Gullberg, D. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102273 · Cited by 30
Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer
Li, Z., Mo, F., Guo, K., Ren, S., Wang, Y., Chen, Y., Schwartz, P. B., Richmond, N., Liu, F., Ronnekleiv‐Kelly, S. M., et al. (2024) · Med · doi:10.1016/j.medj.2024.02.012 · Cited by 32
Self-citation
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)
Shen, Y., Sun, L., Wang, S., Zheng, X., & Xu, R. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5706 · Cited by 32
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies
Belli, C., Antonarelli, G., Repetto, M., Bielo, L. B., Crimini, E., & Curigliano, G. (2022) · Cancers · doi:10.3390/cancers14174278 · Cited by 31
Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinoma
You, R., Shen, Q., Lin, C., Dong, K., Liu, X., Xu, H., Hu, W., Xie, Y., Xie, R.-Q., Song, X., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02253-8 · Cited by 38
SLC35F2–SYVN1–TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53
Che, B., Du, Y., Yuan, R., Xiao, H., Zhang, W., Shao, J., Lu, H., Yu, Y., Xiang, M., Hao, L., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02843-y · Cited by 29
KLF5 governs sphingolipid metabolism and barrier function of the skinPreprint
Lyu, Y., Guan, Y., Deliu, L. P., Humphrey, E., Frontera, J. K., Yang, Y. J., Zamler, D. B., Kim, K. H., Mohanty, V., Jin, K., et al. (2022) · Genes & Development · doi:10.1101/gad.349662.122 · Cited by 30
Self-citation
Weighted gene coexpression network analysis and machine learning reveal oncogenome associated microbiome plays an important role in tumor immunity and prognosis in pan-cancer
Guan, S.-W., Lin, Q., Wu, X., & Yu, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04411-0 · Cited by 28
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment
Fuller, A. M., Pruitt, H. C., Liu, Y., Irizarry-Negron, V. M., Pan, H., Song, H., Devine, A., Katti, R., Devalaraja, S., Ciotti, G. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci167826 · Cited by 26
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
Kyriazi, A. A., Karaglani, M., Agelaki, S., & Baritaki, S. (2024) · Cells · doi:10.3390/cells13151279 · Cited by 27
ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner
Li, R.-K., Ji, Q., Fu, S., Gu, J., Liu, D., Wang, L., Yuan, X., Wen, Y., Dai, C., & Li, H. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00864-7 · Cited by 28
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
Karsdal, M. A., Cox, T. R., Parker, A. L., Willumsen, N., Sand, J. M. B., Jenkins, G. R., Hansen, H. H., Oldenburger, A., Geillinger‐Kästle, K. E., Larsen, A. T., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061856 · Cited by 29
Self-citation
Natural multi-osmolyte cocktails form deep eutectic systems of unprecedented complexity: discovery, affordances and perspectives
Bubalo, M. C., Andreou, T., Panić, M., Radović, M., Radošević, K., & Redovniković, I. R. (2023) · Green Chemistry · doi:10.1039/d2gc04796a · Cited by 29
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Owaki, T., Iida, T., Miyai, Y., Kato, K., Hase, T., Ishii, M., Ando, R., Hinohara, K., Akashi, T., Mizutani, Y., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02734-3 · Cited by 27
Collagen remodeling-mediated signaling pathways and their impact on tumor therapy
Yuan, Z., Lin, B., Wang, C., Yan, Z., Yang, F., & Su, H. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108330 · Cited by 26
Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis
MacDonald, E., Forrester, A. R., Valades‐Cruz, C. A., Madsen, T. D., Hetmanski, J. H. R., Dransart, E., Ng, Y., Godbole, R. K., Ananthan, A. S., Leconte, L., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01616-x · Cited by 25
Bioprinted Patient‐Derived Organoid Arrays Capture Intrinsic and Extrinsic Tumor Features for Advanced Personalized Medicine
Han, J., Jeong, H., Choi, J., Kim, H., Kwon, T., Myung, K., Park, K., Park, J. I., Sánchez, S., Jung, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202407871 · Cited by 30
Targeting collagen to optimize cancer immunotherapy
Wang, Y., Zhang, F., Qian, Z., Ying, J., Wu, D., Liu, L., Ning, X., Mei, J., Chen, D., & Zhang, Y. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00691-y · Cited by 28
Insights into the relevance of targeting fibroblasts to control cancer
Boeker, V., & Kalluri, R. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102395 · Cited by 25
Self-citation
Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
Kuznetsova, A. V., Попова, О. П., Panchenkov, D. N., Dyuzheva, Т. G., & Aa, I. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00886-1 · Cited by 24
Profiling of Tumor Cell‐Delivered Exosome by Surface Enhanced Raman Spectroscopy‐Based Biosensor for Evaluation of Nasopharyngeal Cancer Radioresistance
Wu, Q., Ding, Q., Lin, W., Weng, Y., Feng, S., Chen, R., Chen, C., Qiu, S., & Lin, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202482 · Cited by 25
Recombinant humanized collagen type III with high antitumor activity inhibits breast cancer cells autophagy, proliferation, and migration through DDR1
Liu, X., Li, H., Wang, T., Yang, T., Yang, X., Guo, K., Hu, L., & Ming, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125130 · Cited by 25
Loss of attachment promotes proline accumulation and excretion in cancer cells
Pilley, S. E., Hennequart, M., Vandekeere, A., Blagih, J., Legrave, N. M., Fendt, S., Vousden, K. H., & Labuschagne, C. F. (2023) · Science Advances · doi:10.1126/sciadv.adh2023 · Cited by 24
Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
Song, T., Kong, B., Liu, R., Luo, Y., Wang, Y., & Zhao, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300984 · Cited by 24
A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism
Li, M., Freeman, S. R., Franco‐Barraza, J., Cai, K. Q., Kim, A., Jin, S., Cukierman, E., & Ye, K. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122631 · Cited by 24
Glycosylation in the tumor immune response: the bitter side of sweetness
Cao, Y., Yi, W., & Zhu, Q. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024107 · Cited by 23
Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering
Song, S., Liu, Z., Wang, Y., & Gong, B. (2025) · Medicine Bulletin · doi:10.1002/mdb2.70001 · Cited by 25
Fibrotic Fortresses and Therapeutic Frontiers: Pancreatic Stellate Cells and the Extracellular Matrix in Pancreatic Cancer
Sığırlı, S., & Karakaş, D. (2025) · Cancer Medicine · doi:10.1002/cam4.70788 · Cited by 24
The extracellular matrix in inflammation and cancer
Zhang, W., Xiang, Y., Lu, C., Wang, F., Ren, H., Wu, H., & Yan, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00415-6 · Cited by 34
New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma
Xia, J., Shi, Y., & Chen, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-72020-y · Cited by 20
Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer
Wang, M., Wang, Y., Pan, X., Wang, W., Wang, Y., Luo, X., Deng, X., Liu, L., Chen, X., Zhai, X., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2500019122 · Cited by 22
Self-citation
Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
Penny, M. K., Lerário, A. M., Basham, K. J., Chukkapalli, S., Yu, Y., Mohan, D. R., LaPensee, C. R., Converso‐Baran, K., Hoenerhoff, M. J., Suárez–Fernández, L., et al. (2023) · Cancers · doi:10.3390/cancers15143559 · Cited by 20
Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy
Liu, J., Pan, D., Huang, X., Wang, S., Chen, H., Zhu, Y. Z., & Ye, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1225483 · Cited by 19
The war between the immune system and the tumor - using immune biomarkers as tracers
Yang, K., Lu, R., Mei, J., Cao, K., Zeng, T., Hua, Y., Huang, X., Li, W., & Yin, Y. (2024) · Biomarker Research · doi:10.1186/s40364-024-00599-5 · Cited by 22
HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy
Shi, H., Yuan, M., Cai, J., Lan, L., Wang, Y., Wang, W., Zhou, J., Wang, B., Yu, W., Dong, Z., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05098-7 · Cited by 18
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis
Su, D., Wang, R., Chen, G., Ding, C., Liu, Y., Tao, J., Wang, Y., Qiu, J., Luo, W., Weng, G., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3638 · Cited by 18
CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment
Xu, H., Xue, S., Sun, Y., Ma, J., Li, S., Wang, Y., Mao, T., Ge, W., Yue, M., Shentu, D., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010029 · Cited by 18
Halofuginone Disrupted Collagen Deposition via mTOR‐eIF2α‐ATF4 Axis to Enhance Chemosensitivity in Ovarian Cancer
Li, W., Wu, Y., Zhang, Y., Gao, W., Li, X., Luo, H., Lu, M., Liu, Z., & Luo, A. (2025) · Advanced Science · doi:10.1002/advs.202416523 · Cited by 22
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice
Li, Q., Yang, C., Li, J., Wang, R., Min, J., Song, Y., & Su, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06778-8 · Cited by 21
Emerging technologies and current challenges in intratumoral microbiota research
Wang, Z., Zhang, T., & Liu, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1685862 · Cited by 18
COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation
Song, Y. H., Wang, L., Wang, K., Lu, Y., & Zhou, P. (2023) · Cancers · doi:10.3390/cancers15051480 · Cited by 20
The effect mechanism of polysaccharides inhibit tumor immune escape: A review
Yang, K., Chen, J., Chen, J., Wang, Z., Song, B., Li, R. Q., Zhong, S., & Cheong, K. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105638 · Cited by 19
The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen
Revert‐Ros, F., Ventura, I., Prieto-Ruiz, J. Á., Hernández‐Andreu, J. M., & Revert, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126523 · Cited by 18
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
Bailey, P. J., Zhou, X., An, J., Peccerella, T., Hu, K., Springfeld, C., Büchler, M. W., & Neoptolemos, J. P. (2023) · Function · doi:10.1093/function/zqad011 · Cited by 18
Integrative single‐cell sequencing analysis distinguishes survival‐associated cells from the breast cancer microenvironment
Huang, L., Qin, S., Xia, L., Ma, F., & Chen, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5892 · Cited by 16
The phase separation of extracellular matrix protein matrilin‐3 from cancer‐associated fibroblasts contributes to gastric cancer invasion
Huang, Y., Xiao-yang, X., Lu, Y., Sun, Q., Zhang, L., Shao, J., Chen, D., Chang, Y., Sun, X., Zhuo, W., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202301524r · Cited by 16
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics
Qian, J., Zhang, X., Wei, B., Tang, Z., & Zhang, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188943 · Cited by 16
Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma
Lee, D. U., Han, B. S., Jung, K. H., & Hong, S. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.029 · Cited by 16
Pharmacomicrobiomics in precision cancer therapy: bench to bedside
Ngoc, K. L., Pham, T. T. H., Nguyen, T. K., & Huong, P. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428420 · Cited by 17
Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis
Yang, D., Moniruzzaman, R., Wang, H., Wang, H., & Chen, Y. (2023) · Cancers · doi:10.3390/cancers15082396 · Cited by 13
Self-citation
Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression
Liu, J., Chai, X., Qiu, X.-R., Sun, W., Tian, Y., Guo, W., Yin, D., & Zhang, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133074 · Cited by 14
Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models
Avsharian, L. C., Loganathan, S., Ebelt, N. D., Shalamzari, A. F., Muñoz, I. R., & Manuel, E. R. (2024) · Biomolecules · doi:10.3390/biom14111458 · Cited by 15

Authors: Chen, Y., Yang, S., Tavormina, J., Tampe, D., Zeisberg, M., Wang, H., Mahadevan, K. K., Wu, C.-J., Sugimoto, H., Chang, C.-C., Jenq, R. R., McAndrews, K. M., & Kalluri, R.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Universitätsmedizin Göttingen (DE)
Corresponding author: Kalluri, Raghu
ORCID: Chen, Yang
Yang, Sujuan
Tavormina, Jena
Zeisberg, Michael
Wang, Huamin
Mahadevan, Krishnan K.
Wu, Chang-Jiun
Sugimoto, Hikaru
Chang, Chia-Chi
Jenq, Robert R.
McAndrews, Kathleen M.
Kalluri, Raghu
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2022-08
Volume: 40
Issue: 8
Pages: 818-834.e9
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccell.2022.06.011
PMC: PMC9831277
OpenAlex: W4286267917
Cited by: 289
References: 69
Citations by year: 2026: 48 · 2025: 82 · 2024: 100 · 2023: 49 · 2022: 10
FWCI: 26.79
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 372 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders: Sid W. Richardson Foundation (P30CA016672)
National Cancer Institute (P01CA117969, P30CA16672)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: alpha3beta1 integrin, pancreatic ductal adenocarcinoma, tumor microbiome, Bacteroidales, Campylobacterales, tumor hypoxia, immunosuppression, T cell infiltration, anti-PD-1 therapy, antitumor immunity, tumor organoids, tumor cell proliferation
MeSH terms: Animals, Collagen, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Collagen Type I, Integrin alpha3beta1, Mice, Carcinogenesis, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks